[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355605-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355605-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-machine-learning-based-epigenetic-signature-reveals-ythdc1-stabilizes-pou5f1-to-oppose-tumor-progression","A machine learning-based epigenetic signature reveals YTHDC1 stabilizes POU5F1 to oppose tumor progression","","Bladder cancer prognosis and progression show marked heterogeneity driven by complex genetic and epigenetic alterations. A machine learning workflow was used to build a robust prognostic signature from epigenetic modification-related genes in the TCGA-BLCA cohort, then validated across multiple independent datasets. The model’s clinical, genetic and transcriptomic associations were characterized, including immune infiltration and drug response patterns. Mechanistic studies focused on YTHDC1 binding and stabilizing POU5F1 mRNA to restrain proliferation and migration, dependent on POU5F1.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-machine-learning-based-epigenetic-signature-reveals-ythdc1-stabilizes-pou5f1-to-oppose-tumor-progression/355605/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-machine-learning-based-epigenetic-signature-reveals-ythdc1-stabilizes-pou5f1-to-oppose-tumor-progression/355605.png","ImageObject",300,407,{"name":42,"@type":43},"Fahsai","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main goal of the study?","Question",{"text":63,"@type":64},"To construct a robust prognostic signature based on epigenetic modification-related genes and to uncover molecular mechanisms explaining its predictive value.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the epigenetic prognostic signature developed and validated?",{"text":68,"@type":64},"A machine learning approach screened epigenetic genes in the TCGA-BLCA cohort, with performance evaluated against many algorithms and previously published signatures across four independent validation datasets.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism connects YTHDC1 to tumor progression in bladder cancer?",{"text":72,"@type":64},"YTHDC1 was shown to bind and stabilize POU5F1 (OCT4) mRNA, inhibiting proliferation and migration in bladder cancer cell lines, and this anti-tumor effect depended on POU5F1.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355605,1790734172,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":109,"preview_page_count":33,"preview_urls":146},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","Fang et al. Journal of Translational Medicine (2026) 24:608  \n[https://doi.org/10.1186/s12967-026-08010-7](https://doi.org/10.1186/s12967-026-08010-7)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nA machine learning-based epigenetic signature reveals YTHDC1 stabilizes POU5F1 to oppose tumor progression  \nChen Fang1†, Jun Dai1†, Zhiwei Weng2†, Lianhua Zhang3, Yutong Xing4, Diamond Liu4, Hui Wu3, Xuanhao Li5,6*, Qiang Liu3,6* and Gangling Su7*  \nAbstract  \nBackground The prognosis and progression mechanisms of bladder cancer (BLCA) are highly heterogeneous, driven by complex genetic and epigenetic alterations. This study aimed to construct a robust prognostic signature using epigenetic modification-related genes and to investigate the underlying molecular mechanisms driving its predictive power.  \nMethods We developed a prognostic signature by applying a machine learning-based approach to screen epigenetic genes in theTCGA (The Cancer Genome Atlas)-BLCA cohort. Its performance was rigorously evaluated against 101 other machine learning algorithms and 110 previously published signatures across four independent validation datasets (IMvigor210, E-MTAB-4321, GSE31684, GSE48075) . Associations with clinical, genetic, and transcriptomic features were analyzed. Immune infiltration, cell-cell interactions, and drug responses were assessed using both bulk and single-cell RNA-seq data. The functional role of a key signature gene, YTHDC1 (YTH DomainContaining 1), was investigated through in vitro assays.  \nResults A six-gene epigenetic signature was constructed. It significantly stratified patients into high-and low  \nrisk groups with distinct overall survival (median survival 20.5 vs. 86.8 months, HR = 2 . 12, p = 7 . 7e-7) . Our signature demonstrated superior predictive accuracy (C-index and 1-year AUROC) compared to other models. High-risk scores correlated with adverse clinical features (e. g., advanced stage), elevated PD-1/PD-L1, higher genomic instability, and immunosuppressive microenvironments. Single-cell analysis revealed altered T-cell interactions in high-risk cases. Mechanistically, YTHDC1 was shown to bind and stabilize POU5F1 (OCT4) mRNA, thereby inhibiting proliferation and migration in BLCA cell lines (T24, 5637) . This anti-tumor effect was dependent on POU5F1 .  \n†Chen Fang, Jun Dai and Zhiwei Weng contributed equally to this work.  \n*Correspondence: Xuanhao Li[xuanhaoli@ccmu.edu.cn](xuanhaoli@ccmu.edu.cn)[ ](xuanhaoli@ccmu.edu.cn)Qiang Liu [lqws_sjtu@163.com](lqws_sjtu@163.com)[ ](lqws_sjtu@163.com)Gangling Su [gangling2004@126.com](gangling2004@126.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nFang et al. Journal of Translational Medicine (2026) 24:608 Page 2 of 16  \nConclusion The machine learning-derived epigenetic signature is a robust indica","cbCaij9RhvtR30Jx","https://ap.wps.com/l/cbCaij9RhvtR30Jx","pdf",9364910,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Epidemiology and clinical challenge\n## Prior biomarker research\n## Rationale for robust epigenetic mechanisms","[{\"question\":\"What was the main goal of the study?\",\"answer\":\"To construct a robust prognostic signature based on epigenetic modification-related genes and to uncover molecular mechanisms explaining its predictive value.\"},{\"question\":\"How was the epigenetic prognostic signature developed and validated?\",\"answer\":\"A machine learning approach screened epigenetic genes in the TCGA-BLCA cohort, with performance evaluated against many algorithms and previously published signatures across four independent validation datasets.\"},{\"question\":\"What mechanism connects YTHDC1 to tumor progression in bladder cancer?\",\"answer\":\"YTHDC1 was shown to bind and stabilize POU5F1 (OCT4) mRNA, inhibiting proliferation and migration in bladder cancer cell lines, and this anti-tumor effect depended on POU5F1.\"}]","A machine learning-based epigenetic signature reveals YTHDC1 stabilizes POU5F1 to oppose tumor progression | PDF",1790120118,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c33f74d7bd6e92ea02e63a19fd4b32f1.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c4bc09ad053c3cfcfbe180758b4ad3c.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0f4fd2c16c135bf2f242eba9a9087d4.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b8dc0b33fe9ee2dc98a832c313a2271.webp",980,1306]